Tag: Bruton’s tyrosine kinase
AstraZeneca’s Calquence shows promising clinical improvement in Covid-19 patients
Results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor, reduced markers of inflammation and improved clinical outcomes of...